---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-202614"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-14T23:54:36.047291+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health receives Nasdaq delisting notice for insufficient publicly held shares after reverse split

## Summary
- Post 1-for-35 reverse stock split on April 30, 2026, publicly held shares are ~401,226, below 500,000 minimum.
- Nasdaq Staff notified company on May 1, 2026 of additional deficiency under Listing Rule 5550(a)(4).
- Company must present views to Nasdaq Hearings Panel by May 8, 2026; failure may lead to delisting.
- Company remains non-compliant with both minimum bid price and public shares requirements.

## SEC filing metadata
- accession: 0001193125-26-202614
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526202614/0001193125-26-202614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526202614/d46623d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-202614
- JSON: https://secwatch.observer/filing/0001193125-26-202614.json
- Plain text: https://secwatch.observer/filing/0001193125-26-202614.txt

## Source-grounded claims
- claim_id: 39247c9141f4e94b7885fc7f98233db529817968
  claim: Jaguar Health, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(4), 5810(d), 5810(c)(3)(A)).
  evidence_excerpt: May 1, 2026, Jaguar Health, Inc. (the “Company”) received a written notification (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying th
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526202614/0001193125-26-202614-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.